Life Sciences Archives

Preventing the next pandemic: mRNA vaccines and siRNA oligo therapies

Investing in promising new pharmaceutical platforms like oligonucleotide therapies could reduce the gap between first detection and total eradication in future pandemics.

Viral vectors—beyond the yellow brick road

The science of viral vector manufacturing is generating a lot of excitement, and companies in this space are under pressure to move fast and make cost-effective decisions; this can occasionally result in speed at the expense of due diligence.

Vaccines—our best long-term defense

Not a treatment, but a cure, vaccines are extremely important because they help us develop lifelong immunity to diseases.

Multimodal ATMP facilities to satisfy growing demand

Multimodal manufacturing optimizes product combinations based on manufacturing and regulatory similarity and compatibility. Manufacturers must produce a variety of Advanced Therapy Medicinal Products (ATMPs) quickly and efficiently. Why not design a multi-modal ATMP facility?

The greatest hazard for incubator labs? Inadequately managed hazardous chemicals

Developers creating multi-tenant spaces for life science startups need to consider something most other industries don’t: how hazardous chemicals play a role in their tenants’ work and the design of the building.

5 ways to use data to prepare your facility for a pandemic

With the rapid, global spread of COVID-19, advanced data analytics and tools are now more important for the healthcare industry and academic institutions than ever before.

5 considerations for laboratory site selection

When planning for a new laboratory or expanding your current operation, sometimes location can limit availability, or size can impact the structural capability of a space. Every site will have pros and cons. That’s why it’s important to consider these five things during site selection.